Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study.
第一作者:
S,Kanda
第一单位:
Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo skanda@ncc.go.jp.
作者:
主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);紫杉酚(Paclitaxel);紫杉烷类(Taxoids)
DOI
10.1093/annonc/mdw416
PMID
27765756
发布时间
2022-12-07
- 浏览59

Annals of oncology
2242-2250页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文